VNVALUEVNVALUE
Updated weekly
Back to Dashboard
Consumer sector

DDN

Consumer
Công ty Cổ phần Dược - Thiết bị y tế Đà Nẵng
Y tế/Dược phẩmCT
11.000
VND · Last close
Valuation Verdict
Overvalued
Very Low
-120%Fair Value+120%
Intrinsic Value
6.425
Current
11.000
Gap
-41.6%
ModelFCF DCF

Valuation Breakdown

CTY tếConsumer
Classified as consumer because ICB sector "Y tế" maps to the consumer group
ModelFCF-Based DCF
Value = Sum of [FCF / (1+WACC)^t] + Terminal Value / (1+WACC)^n

A classic Discounted Cash Flow model built on Free Cash Flow (FCF), the actual cash a business generates after all operating expenses and capital expenditures. Future FCF is projected for 10 years with gradually decaying growth, then discounted back to today's value using WACC. This is the gold standard of intrinsic valuation: it values the company based on what it can actually deliver to shareholders, independent of market sentiment.

Distressed Valuation
Negative Intrinsic Value
BVPS
12.850
x
Discount
50%
=
Floor Value
12.850

Valuation Track Record

Retroactive intrinsic value vs actual close price — DDN

Earnings Quality

Fiscal year 2025

23
Poor
Accrual Quality
91
Cash Conversion
0
Receivables
0
Margin Stability
0
Revenue Quality
0

Financial Forensics

Beneish M-Score · 2025

-2.63
Low Risk
DSRI
1.204
GMI
0.726
AQI
1.065
SGI
0.767
DEPI
0.428
SGAI
1.363
TATA
0.023
LVGI
0.961

The Beneish M-Score of -2.6263 indicates a low likelihood of earnings manipulation, as it is below the manipulation threshold of -1.78. However, the poor earnings quality score of 22.7/100, particularly the zero scores in cash conversion and receivables, raises concerns about the sustainability of reported earnings.

Red Flags
  • Earnings Quality Score of 22.7/100, indicating significant issues with cash conversion and receivables.
  • SGAI at 1.3627 suggests aggressive sales growth that may not be supported by actual cash flows.
Positive Signals
  • Beneish M-Score of -2.6263 indicates a low likelihood of earnings manipulation.
  • High accrual score of 90.8/100 suggests that reported earnings may be based on legitimate accrual accounting practices.
Ownership Risk

The top shareholder, Công ty Cổ phần Megram, holds a significant 51.0% stake, which may lead to potential conflicts of interest and reduced minority shareholder influence.

Recommendation

Investors should closely monitor cash flow metrics and consider the implications of the ownership structure before making investment decisions. A deeper analysis of operational performance and sales sustainability is recommended.

Generated by AI based on quantitative data. Not financial advice.

Quantitative Scores

F-Score
3/9
Weak
Z-Score
1.31
Distress Zone
Sharpe
0.10
Positive
Composite
31
Weak
Price Risk
Momentum
+13.2%
Volatility
66.9%
Max Drawdown
-25.2%

Key Ratios

Fiscal year 2025
44.15P/E
P/B0.86
P/S0.17
ROE2.0%
ROA0.4%
EPS250.58
BVPS12849.65
Gross Margin8.9%
Net Margin0.4%
D/E3.86
Current Ratio1.15
Rev Growth-23.3%
Profit Growth-47.0%
EV/EBITDA22.97
Div Yield0.0%

Company Overview

Issued Shares
16.1M
Charter Capital
161.2B VND
Sector (ICB L2)
Y tế
Industry (ICB L3)
Dược phẩm
Sub-industry
Dược phẩm
Company Type
CT

// OWNERSHIP_NETWORK

> mapping common ownership for DDN — hover nodes for intel, click to navigate

Shareholders
Công ty Cổ phần Megram
Inst
51.0%
7.8 trieu
Đỗ Thành Trung
Indiv
10.4%
1.7 trieu
Công ty Cổ phần Dược Danapha
Inst
7.2%
1.1 trieu
Vũ Thiện Tiệp
Indiv
6.8%
1.1 trieu
Công ty cổ phần SPM
Inst
2.9%
145.800
Tống Viết Phải
Indiv
0.4%
58.608
Trần Nhân Triết
Indiv
0.4%
40.961
Đặng Văn Nam
Indiv
0.4%
19.974
Nguyễn Hữu Công
Indiv
0.4%
48.816
Phan Thịnh
Indiv
0.3%
16.578
Nguyễn Lương Tâm
Indiv
0.3%
47.735
Võ Văn Chín
Indiv
0.3%
15.534
Phan Thị Thùy Linh
Indiv
0.3%
41.923
Nguyễn Ngọc Hổ
Indiv
0.2%
11.440
Nguyễn Hữu Thoại
Indiv
0.2%
10.422
Trần Thị Lợi
Indiv
0.2%
10.062
Võ Anh Hùng
Indiv
0.2%
22.109
nguyen-ba-hai
Indiv
0.1%
23.675
Trần Thị Ánh Minh
Indiv
0.1%
20.160
Nguyễn Thị Thuận
Indiv
0.1%
6.336
Nguyễn Thị Hoài Phương
Indiv
0.1%
12.704
Nguyễn Trung
Indiv
0.1%
19.268
Board & Management
Đỗ Thành Trung10.4%
Chủ tịch Hội đồng Quản trị
Tống Viết Phải0.4%
Phó Chủ tịch Hội đồng Quản trị
Nguyễn Hữu Công0.4%
Thành viên Hội đồng Quản trị/Phó Tổng Giám đốc
Trần Thị Ánh Minh0.1%
Kế toán trưởng
Nguyễn Thị Thanh Thúy
Thành viên Ban kiểm soát
Trần Thị Phương
Trưởng Ban kiểm soát/Thành viên Ban kiểm soát
Đinh Thị Mộng Vân
Thành viên Hội đồng Quản trị
Phạm Thị Minh Ngọc
Người phụ trách quản trị công ty
Phạm Ngọc Hà
Phụ trách Công bố thông tin
Phạm Thị Minh Ngọc
Thành viên Ban kiểm soát
Nguyễn Công Lâm
Tổng Giám đốc/Thành viên Hội đồng Quản trị
Computed 12/04/2026
Methodology & Disclosure

vnvalue is a methodology engine — not an advisor. Every number is the deterministic output of a published formula applied to public financial data. Nothing on this page constitutes investment, financial, legal, or tax advice, nor a recommendation to buy, sell, or hold any security.

All data, models, and outputs are provided AS IS without warranty of any kind. You are solely responsible for your investment decisions. Past performance and historical valuations are not indicative of future results.

By using vnvalue you accept the Terms of Service and Privacy Policy. Full disclaimer →